← Back to headlines
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline
An analysis suggests a specific rare-disease specialist company has a superior portfolio and pipeline compared to Centessa Pharmaceuticals.
26 Feb, 18:50 — 26 Feb, 18:50
Sources
Showing 1 of 1 sources
Related Stories
Philippines Faces Rising Fuel Costs Amid Maundy Thursday Observance
just now
Bosnia and Herzegovina's Indirect Tax Revenue Rises in Q1 2026
4m ago
Philippines Launches Initiatives to Aid Sectors Affected by Soaring Oil Prices
6m ago
Global Markets React to Trump's Aggressive Middle East Stance, Gold Prices Fall
9m ago